Literature DB >> 4878639

Factors which may influence the effectiveness of L-asparaginases as tumor inhibitors.

J D Broome.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4878639      PMCID： PMC2008400          DOI： 10.1038/bjc.1968.71

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  6 in total

1.  MECHANISM OF LACTATE DEHYDROGENASE (LDH) ELEVATION IN VIRUS-INFECTED HOSTS.

Authors:  V RILEY; J D LOVELESS; M A FITZMAURICE; W M SILER
Journal:  Life Sci (1962)       Date:  1965-02

Review 2.  LACTIC DEHYDROGENASE VIRUS.

Authors:  A L NOTKINS
Journal:  Bacteriol Rev       Date:  1965-06

3.  Lactic dehydrogenase activity in blood.

Authors:  F WROBLEWSKI; J S LADUE
Journal:  Proc Soc Exp Biol Med       Date:  1955-10

4.  Two L-asparaginases from E. coli and their action against tumors.

Authors:  J H Schwartz; J Y Reeves; J D Broome
Journal:  Proc Natl Acad Sci U S A       Date:  1966-11       Impact factor: 11.205

5.  A comparison of concurrent and delayed tests for antitumor activity of L-asparaginase.

Authors:  L T Mashburn; E A Boyse; H A Campbell; L J Old
Journal:  Proc Soc Exp Biol Med       Date:  1967-02

6.  Transmissible Agent Associated with 26 Types of Experimental Mouse Neoplasms.

Authors:  V Riley; F Lilly; E Huerto; D Bardell
Journal:  Science       Date:  1960-08-26       Impact factor: 47.728
  6 in total
  13 in total

1.  Differential asparaginase sensitivity of T-cell and B-cell responses.

Authors:  M C Berenbaum; W A Cope; W Jeffery
Journal:  Clin Exp Immunol       Date:  1973-12       Impact factor: 4.330

2.  Biochemical properties of yeast L-asparaginase.

Authors:  G E Jones; R K Mortimer
Journal:  Biochem Genet       Date:  1973-06       Impact factor: 1.890

3.  L-Asparaginase production by the rumen anaerobe Vibrio succinogenes.

Authors:  D Kafkewitz; D Goodman
Journal:  Appl Microbiol       Date:  1974-01

4.  [Blood level course in humans following administration of 2 various kinds of L-asparaginase].

Authors:  J Pütter; G Gehrmann
Journal:  Klin Wochenschr       Date:  1969-12-15

Review 5.  Overview of the structure, side effects, and activity assays of l-asparaginase as a therapy drug of acute lymphoblastic leukemia.

Authors:  Nanxiang Wang; Wenhui Ji; Lan Wang; Wanxia Wu; Wei Zhang; Qiong Wu; Wei Du; Hua Bai; Bo Peng; Bo Ma; Lin Li
Journal:  RSC Med Chem       Date:  2022-01-12

6.  Asparagine deprivation mediated by Salmonella asparaginase causes suppression of activation-induced T cell metabolic reprogramming.

Authors:  AnnMarie Torres; Joanna D Luke; Amy L Kullas; Kanishk Kapilashrami; Yair Botbol; Antonius Koller; Peter J Tonge; Emily I Chen; Fernando Macian; Adrianus W M van der Velden
Journal:  J Leukoc Biol       Date:  2015-10-23       Impact factor: 4.962

7.  The cross-reactivity of anti-asparaginase antibodies against different L-asparaginase preparations.

Authors:  Beata Zalewska-Szewczyk; Agnieszka Gach; Krystyna Wyka; Jerzy Bodalski; Wojciech Młynarski
Journal:  Clin Exp Med       Date:  2009-01-30       Impact factor: 3.984

8.  Recombinant deamidated mutants of Erwinia chrysanthemi L-asparaginase have similar or increased activity compared to wild-type enzyme.

Authors:  David Gervais; Nicholas Foote
Journal:  Mol Biotechnol       Date:  2014-10       Impact factor: 2.695

9.  Production and properties of asparaginase from a new Erwinia sp.

Authors:  B Borkotaky; R L Bezbaruah
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

10.  Isolation and characterization of a Chlamydomonas L-asparaginase.

Authors:  J H Paul
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.